Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2008
05/15/2008WO2008056596A1 Polymeric derivative of nucleic acid metabolic antagonist
05/15/2008WO2008056388A1 Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof
05/15/2008WO2008056335A1 5-hydroxymethyl-oxazolidin-2-one derivatives
05/15/2008WO2008056264A2 Novel nucleotide analogues as percursor molecules for antivirals
05/15/2008WO2008056149A1 Quinazoline derivatives and pharmaceutical compositions containing them
05/15/2008WO2008055963A1 Novel method for producing organic phosphorus compounds, phosphorus compounds produced using said method, the metal complexes of said compounds, and use of same
05/15/2008WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
05/15/2008WO2008039420A3 Novel inhibitors of beta-lactamase
05/15/2008WO2008001278A3 Extracts of plectranthus hadiensis, argenatus or myrianthus for the treatment of microbial infection
05/15/2008US20080114068 HIV antiviral agents; 2-((p-carboxyphenyl)aminocarbonylmethoxy)-5-halo-benzophenone compounds
05/15/2008US20080114055 By using [3-(3,4-Dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethyl-ammonium chloride to reduce or reverse cachexia or disease-induced body weight loss
05/15/2008US20080114019 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide
05/15/2008US20080114015 NF-kB inhibitors and uses thereof
05/15/2008US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
05/15/2008US20080113975 Thiourea compounds
05/15/2008US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use
05/15/2008US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection
05/15/2008US20080113906 Sushi Peptide Multimer
05/15/2008US20080113003 Animal feed with sinapic acid; beneficial bacteria, Bifidocacterium, propionibacterium in the gastrointestinal tract increase in numbers while detrimental bacteria, Escherichia and Salmonella
05/15/2008US20080112977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof
05/15/2008US20080112975 Inducing adaptive immune response against a tumor or a pathogen via tissue destruction, followed by engraftment of allogenic cell adjuvants to region of tissue destruction; antitumor agents
05/15/2008US20080112969 Comprising a US2 gene having inserted a foreign DNA sequence capable of being expressed in a host cell that has been infected by the recombinant avian herpes virus; bird vaccines for Marek's disease, Newcastle disease and the infectious laryngotracheitis virus; veterinary medicine; genetic vectors
05/15/2008US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals
05/15/2008DE102006053500A1 Antimicrobial compounds for controlling selective microorganisms such as gram-positive bacteria, particularly coryneform bacteria, has general formula
05/15/2008CA2669450A1 Novel nucleotide analogues as percursor molecules for antivirals
05/15/2008CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
05/15/2008CA2668280A1 5-hydroxymethyl-oxazolidin-2-one derivatives
05/15/2008CA2665778A1 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
05/14/2008EP1921136A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/14/2008EP1921094A2 Method for presenting and removing substances
05/14/2008EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof
05/14/2008EP1920783A1 Recombinant RSV virus expression systems and vaccines
05/14/2008EP1920777A1 Extraction method for the fractioned preparation and separation of plant ingredients and use thereof
05/14/2008EP1920775A1 5'Triphosphate oligonucleotide induces anti-viral response
05/14/2008EP1920773A1 Compositions for inhibition of anglogenesis
05/14/2008EP1919921A1 Bicyclic heterocycles as hiv integrase inhibitors
05/14/2008EP1919904A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919899A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919898A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919890A1 Pyrazolone derivatives for the treatment of tuberculosis
05/14/2008EP1919872A2 Chemical compounds
05/14/2008EP1919868A2 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them
05/14/2008EP1919507A2 Nanoparticles comprising antibacterial ligands
05/14/2008EP1919505A2 Single dose use of cd20-specific binding molecules
05/14/2008EP1919457A2 Stable fixed-dose unitary formulation, containing tenofovir, a sufactant, efavirenz and emtricitabine
05/14/2008EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
05/14/2008EP1713776B1 Quinoline derivatives for use as mycobacterial inhibitors
05/14/2008EP1711468B1 Process for preparing purified ciprofloxacin
05/14/2008EP1622584B1 Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
05/14/2008EP1506009B1 Beta-glucan-based anti-fungal vaccines
05/14/2008EP1429789B1 Anti-infectious carbohydrates
05/14/2008EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2008EP1305031B1 Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents
05/14/2008EP1248600B1 Improved hiv protease inhibitors pharmaceutical formulations
05/14/2008EP1242592B1 A molecular switch for regulating mammalian gene expression
05/14/2008EP1235934B1 Screening method for candidate drugs
05/14/2008EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
05/14/2008EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
05/14/2008EP1017418B1 Vaccine composition for preventing or treating c hepatitis
05/14/2008EP0833929B1 Chimeric antibodies for delivery of antigens to selected cells of the immune system
05/14/2008EP0772437B9 Compositions for delivery of genetic material
05/14/2008EP0635132B2 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
05/14/2008EP0471726B2 Acellular vaccine
05/14/2008CN201058029Y System for gathering and producing autoserum eye water
05/14/2008CN101180300A New isothiazoloquinolones and related compounds as anti-infective agents
05/14/2008CN101180298A New antibiotic derivatives
05/14/2008CN101180288A Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
05/14/2008CN101180280A 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors
05/14/2008CN101180271A Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure
05/14/2008CN101180053A Treatment of liver diseases in which iron plays a role in pathogenesis
05/14/2008CN101180051A Method for preparation of aqueous doripenem solution
05/14/2008CN101177451A Micrococcus pyogenes adhesion functional peptide and coded sequence thereof
05/14/2008CN101177433A (s)-ornidazole disodium phosphate pentahydrate as well as preparation method and uses thereof
05/14/2008CN101177413A 6-cyclohexyl methyl substituted S-DABO compound, method for synthesizing same and uses thereof
05/14/2008CN101176775A Medicament for curing hepatitis B
05/14/2008CN101176763A Externally used medicament and preparation method thereof
05/14/2008CN101176748A Rabies virus eliminating medicine
05/14/2008CN101176746A Pharmaceutical composition and uses thereof
05/14/2008CN101176741A Hydroxypropyl-beta-cyclodextrin clathrate, preparing method and application of radix bupleuri volatile oil
05/14/2008CN101176722A Scutellaria glycosides freeze dried injection solution and preparation method thereof
05/14/2008CN101176718A Netilmicin liposome and technique of preparing the same
05/14/2008CN101176477A Five kind of health care snacks made from wheat or rice flour
05/14/2008CN100387622C Strategically modified hepatitis b core proteins and their derivatives
05/14/2008CN100387619C Regulatory/unfolding peptides of ezrin
05/14/2008CN100387618C Acellular pertussis vaccines and method of preparation thereof
05/14/2008CN100387617C HIV peptides, antigens, vaccine compositions, immunoassay kit and method of detecting
05/14/2008CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity
05/14/2008CN100387609C Novel antibiotic preparing process
05/14/2008CN100387597C Amide substituted imidazopyridines
05/14/2008CN100387596C Preparation of 13-hexyl berberine salt and its anti-virus and antibacterial action
05/14/2008CN100387589C Flavanone compound and uses thereof
05/14/2008CN100387587C Process for separating purifying actived tea polyphenols
05/14/2008CN100387574C Preparation of sodium probenecid and potassium probenecid
05/14/2008CN100387301C Materials and methods for immunizing against fiv infection.
05/14/2008CN100387300C Multivalent huma-bovine retavirus vaccine
05/14/2008CN100387299C Avian e. coli vaccine for protection against colibacillosis
05/14/2008CN100387298C Vaccine composition
05/14/2008CN100387297C Preparation process of cow mammitis vaccine
05/14/2008CN100387291C Medicine for treating pulmonary tuberculosis
05/14/2008CN100387271C Medicine for treating hepatitis B
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 1798